CompletedNCT05132699
Enhancing Prolonged Exposure With Cannabidiol to Treat PTSD
Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- San Antonio, United StatesSee all locations and recruitment
- Activities
- Medication described in the protocol · Placebo comparator
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateStarted: April 4, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 21
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 1, Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05132699
- Official title
Show the full official title
Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder: A Pilot Study
Recruitment & locations
CompletedSan Antonio
Questions about this study
Who is behind this study?
The study sponsor is The University of Texas Health Science Center at San Antonio, a university.
Did this study involve medication?
Yes. The study involved medication, including Cannabidiol (CBD) oral solution and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT01861847
7-Keto DHEA for PTSD
United States
CompletedNCT03508700
TNX-102 SL 5.6 mg Taken Daily at Bedtime for PTSD
United States
CompletedNCT00554177
A study for PTSD
United States